Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fernando Caravaca-Fontán

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Prognostication for C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisFernando Caravaca-Fontán, Manuel Praga
Kidney International|February 21, 2026
The expanding role of complement inhibitors in the treatment of IgA nephropathyFernando Caravaca-Fontán, Manuel Praga
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2024
Living With a Rare Glomerular Disease: A Call to Action for Early Diagnosis and Innovation in TreatmentAntonia King, Fernando Caravaca-Fontán
Kidney360|September 30, 2022
Should Corticosteroids be Used To Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: COMMENTARYManuel Praga, Fernando Caravaca-Fontán
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2024
Microscopic hematuria in C3G and IC-MPGNFernando Caravaca-Fontán, Manuel Praga
Clinical Kidney Journal|June 25, 2024
Ten tips on immunosuppression in primary membranous nephropathyHernando Trujillo, Fernando Caravaca-Fontán, Manuel Praga
Kidney International|April 21, 2023
Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy?Eduardo Gutiérrez, Fernando Caravaca-Fontán, Ángel Sevillano
Advances in Kidney Disease and Health|September 14, 2025
Management of Acute Tubulointerstitial NephritisNamrata Krishnan, Fernando Caravaca-Fontán, Manuel Praga
Clinical Kidney Journal|June 25, 2024
Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathyJoana Tavares, Fernando Caravaca-Fontán, Manuel Praga
Current Opinion in Critical Care|September 11, 2019
Acute kidney injury in interstitial nephritisFernando Caravaca-Fontán, Gema Fernández-Juárez, Manuel Praga
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Clinical Journal of the American Society of Nephrology : CJASN|July 1, 2022
Prognostication for C3 Glomerulopathy and Idiopathic Immunoglobulin-Associated Membranoproliferative GlomerulonephritisFernando Caravaca-Fontán, Manuel Praga
Kidney International|February 21, 2026
The expanding role of complement inhibitors in the treatment of IgA nephropathyFernando Caravaca-Fontán, Manuel Praga
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|April 22, 2024
Living With a Rare Glomerular Disease: A Call to Action for Early Diagnosis and Innovation in TreatmentAntonia King, Fernando Caravaca-Fontán
Kidney360|September 30, 2022
Should Corticosteroids be Used To Treat Biopsy-Proven Drug-Induced Acute Interstitial Nephritis?: COMMENTARYManuel Praga, Fernando Caravaca-Fontán
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2024
Microscopic hematuria in C3G and IC-MPGNFernando Caravaca-Fontán, Manuel Praga
Clinical Kidney Journal|June 25, 2024
Ten tips on immunosuppression in primary membranous nephropathyHernando Trujillo, Fernando Caravaca-Fontán, Manuel Praga
Kidney International|April 21, 2023
Is the NefIgArd trial a paradigm shift in the treatment of IgA nephropathy?Eduardo Gutiérrez, Fernando Caravaca-Fontán, Ángel Sevillano
Advances in Kidney Disease and Health|September 14, 2025
Management of Acute Tubulointerstitial NephritisNamrata Krishnan, Fernando Caravaca-Fontán, Manuel Praga
Clinical Kidney Journal|June 25, 2024
Apolipoprotein E in dense deposits: a parting of the ways in C3 glomerulopathyJoana Tavares, Fernando Caravaca-Fontán, Manuel Praga
Current Opinion in Critical Care|September 11, 2019
Acute kidney injury in interstitial nephritisFernando Caravaca-Fontán, Gema Fernández-Juárez, Manuel Praga
Pageof 11